415 related articles for article (PubMed ID: 22685322)
1. PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty.
Huang JV; Greyson CR; Schwartz GG
J Lipid Res; 2012 Sep; 53(9):1738-54. PubMed ID: 22685322
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis.
Ivanova EA; Myasoedova VA; Melnichenko AA; Orekhov AN
Curr Pharm Des; 2017; 23(7):1119-1124. PubMed ID: 27855608
[TBL] [Abstract][Full Text] [Related]
4. Selective peroxisome proliferator-activated receptor-γ modulation to reduce cardiovascular risk in patients with insulin resistance.
Yew T; Toh SA; Millar JS
Recent Pat Cardiovasc Drug Discov; 2012 Apr; 7(1):33-41. PubMed ID: 22044303
[TBL] [Abstract][Full Text] [Related]
5. PPAR gamma gene--a review.
Janani C; Ranjitha Kumari BD
Diabetes Metab Syndr; 2015; 9(1):46-50. PubMed ID: 25450819
[TBL] [Abstract][Full Text] [Related]
6. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
Huang TH; Roufogalis BD
Curr Mol Pharmacol; 2012 Jun; 5(2):241-7. PubMed ID: 22122453
[TBL] [Abstract][Full Text] [Related]
7. Novel benefits of peroxisome proliferator-activated receptors on cardiovascular risk.
Millar JS
Curr Opin Lipidol; 2013 Jun; 24(3):233-8. PubMed ID: 23594710
[TBL] [Abstract][Full Text] [Related]
8. PPAR dual agonists: are they opening Pandora's Box?
Balakumar P; Rose M; Ganti SS; Krishan P; Singh M
Pharmacol Res; 2007 Aug; 56(2):91-8. PubMed ID: 17428674
[TBL] [Abstract][Full Text] [Related]
9. PPAR agonists for the treatment of cardiovascular disease in patients with diabetes.
Wilding JP
Diabetes Obes Metab; 2012 Nov; 14(11):973-82. PubMed ID: 22443197
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors and cardiovascular remodeling.
Schiffrin EL
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1037-43. PubMed ID: 15374828
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery.
Ivanova EA; Parolari A; Myasoedova V; Melnichenko AA; Bobryshev YV; Orekhov AN
J Cardiol; 2015 Oct; 66(4):271-8. PubMed ID: 26072262
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator activated receptor-alpha (PPARα) and PPAR gamma coactivator-1alpha (PGC-1α) regulation of cardiac metabolism in diabetes.
Duncan JG
Pediatr Cardiol; 2011 Mar; 32(3):323-8. PubMed ID: 21286700
[TBL] [Abstract][Full Text] [Related]
13. Role of PPAR in cardiovascular diseases.
Das SK; Chakrabarti R
Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):193-209. PubMed ID: 18221086
[TBL] [Abstract][Full Text] [Related]
14. Regulation of energy metabolism by long-chain fatty acids.
Nakamura MT; Yudell BE; Loor JJ
Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
[TBL] [Abstract][Full Text] [Related]
15. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.
Panunti B; Fonseca V
Vascul Pharmacol; 2006 Jul; 45(1):29-35. PubMed ID: 16777491
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinediones: effects on insulin resistance and the cardiovascular system.
Quinn CE; Hamilton PK; Lockhart CJ; McVeigh GE
Br J Pharmacol; 2008 Feb; 153(4):636-45. PubMed ID: 17906687
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-gamma in vascular biology.
Li J; Wang N
Cardiovasc Hematol Disord Drug Targets; 2007 Jun; 7(2):109-17. PubMed ID: 17584045
[TBL] [Abstract][Full Text] [Related]
18. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
19. [PPAR-gamma receptors, new therapeutic target in metabolic and cardiovascular diseases].
Scheen AJ; Paquot N
Rev Med Liege; 2005 Feb; 60(2):89-95. PubMed ID: 15819371
[TBL] [Abstract][Full Text] [Related]
20. Chicken adipocyte fatty acid-binding protein knockdown affects expression of peroxisome proliferator-activated receptor γ gene during oleate-induced adipocyte differentiation.
Shi H; Zhang Q; Wang Y; Yang P; Wang Q; Li H
Poult Sci; 2011 May; 90(5):1037-44. PubMed ID: 21489952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
